0001385508-22-000111.txt : 20220715 0001385508-22-000111.hdr.sgml : 20220715 20220715160550 ACCESSION NUMBER: 0001385508-22-000111 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220714 FILED AS OF DATE: 20220715 DATE AS OF CHANGE: 20220715 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Skolnick Phil CENTRAL INDEX KEY: 0001358116 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38193 FILM NUMBER: 221086358 MAIL ADDRESS: STREET 1: C/O DOV PHARMACEUTICAL, INC. STREET 2: 433 HACKENSACK AVENUE CITY: HACKENSACK STATE: NJ ZIP: 07601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OPIANT PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001385508 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464744124 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 233 WILSHIRE BLVD STREET 2: SUITE 400 CITY: SANTA MONICA STATE: CA ZIP: 90401 BUSINESS PHONE: (310) 598-5410 MAIL ADDRESS: STREET 1: 233 WILSHIRE BLVD STREET 2: SUITE 400 CITY: SANTA MONICA STATE: CA ZIP: 90401 FORMER COMPANY: FORMER CONFORMED NAME: Lightlake Therapeutics Inc. DATE OF NAME CHANGE: 20091009 FORMER COMPANY: FORMER CONFORMED NAME: Madrona Ventures, Inc. DATE OF NAME CHANGE: 20070108 4 1 wf-form4_165791552674780.xml FORM 4 X0306 4 2022-07-14 0 0001385508 OPIANT PHARMACEUTICALS, INC. OPNT 0001358116 Skolnick Phil C/O OPIANT PHARMACEUTICALS, INC. 233 WILSHIRE BLVD., SUITE 400 SANTA MONICA CA 90401 0 1 0 0 Chief Scientific Officer Common Stock 2022-07-14 4 S 0 627 11.85 D 23818 D These shares were sold to cover tax withholding obligations in connection with the vesting of performance stock units. This transaction was executed in multiple trades at prices ranging from $11.03 to $11.63. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Phil Skolnick 2022-07-15